EUVIMEDEUVIMED entdecken
Crossref

Mannosylated Fluoropolypeptide Nanovaccines Remodeling Tumor Immunosuppressive Microenvironment to Achieve Highly Potent Cancer Immunotherapy

Meng He, Wei Xu, Yuxin Dan, Yue Pan, Yingying Li, Mingsheng Chen, Chang-Ming Dong iD

Advanced Healthcare Materials · 2024-12 · 13 (30)

DOI: 10.1002/adhm.202401354 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 05.09.2024. Verfasst von Meng He und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry and Chemical Engineering, Frontiers Science Center for Transformative Molecules, Shanghai Key Laboratory of Electrical Insulation…. Hauptthemen laut MEDLINE: Tumor Microenvironment, Immunotherapy, Cancer Vaccines. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 70 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Shanghai Natural Science Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

It is challenging for nanovaccines (NVs) to effectively deliver antigens/neoantigens to prime specifically potent immunities and remodel immunosuppressive tumor microenvironment (TME) for combating immune “cold” cancers. Herein, a novel kind of mannosylated fluoropolypeptide NVs of MFPCOFG (i.e., mannosylated fluoropoly( D,L ‐cysteine) ovalbumin‐loaded Fe 2+ ‐gallic acid) is designed that synergistically integrates triple antigen‐metal‐thermoimmunity to remodel immunosuppressive TME and achieve highly potent immunities. MFPCOFG plus near‐infrared irradiation (NIR) effectively facilitated antigen uptake and escape, induced the maturation and antigen cross‐presentations of dendritic cells and macrophages, polarized anti‐inflammatory macrophage phenotype M2 into tumoricial M1, primed potent CD4 + /CD8 + T cells responses, proinflammatory cytokines secretion and immune memory effects, showcasing triple antigen‐metal‐thermoimmunity outperforming combo/mono‐immunity. Importantly, both MFPCOFG + NIR and personalized NVs can remarkably enhance the tumor infiltration of CD4 + /CD8 + T and NK cells to boost potent immunities and long‐lasting memory effects, reduce regulatory T (Tregs) and M2 to remodel immunosuppressive TME in B16‐OVA and 4T1 models, achieving superior tumor prevention, ablation, and tumor relapse and metastasis inhibition, as further orchestrated with anti‐PD‐1. Consequently, this work opens up a new avenue to design biocompatible polypeptide nanovaccines with potent immune‐priming and TME‐remodeling capabilities, holding great potentials to combat immune “cold” cancers with clinic‐used anti‐PD‐1 for cancer immunotherapy and personalized immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor MicroenvironmentImmunotherapyCancer VaccinesAnimalsMiceMice, Inbred C57BLMannoseFemaleNanoparticlesCell Line, TumorPeptidesDendritic CellsHumansNanovaccines

Stichwörter der Autor:innen

antigen deliverycancer immunotherapypolymeric nanovaccinesynergistic immunitytumor microenvironment regulation

Substanzen

Cancer VaccinesMannosePeptidesNanovaccines

Autor:innen und Institutionen

  • School of Chemistry and Chemical Engineering, Frontiers Science Center for Transformative Molecules, Shanghai Key Laboratory of Electrical Insulation and Thermal Aging, Shanghai Jiao Tong University, Shanghai, 200240, P…
  • Institute of Biomedical Engineering, College of Medicine, Southwest Jiaotong University, Chengdu, 610031, P. R. China.
  • The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510120, P. R. China.
  • Shanghai Public Health Clinic Center, Fudan University, Shanghai, 201508, P. R. China.

ORCID-Profile: Chang-Ming Dong

Förderung

  • National Natural Science Foundation of China
  • Shanghai Natural Science Fund

Zitieren

APA

He, M., Xu, W., Dan, Y., Pan, Y., Li, Y., Chen, M., & Dong, C. M. (2024). Mannosylated Fluoropolypeptide Nanovaccines Remodeling Tumor Immunosuppressive Microenvironment to Achieve Highly Potent Cancer Immunotherapy. Advanced Healthcare Materials, 13(30). https://doi.org/10.1002/adhm.202401354

Vancouver

He M, Xu W, Dan Y, Pan Y, Li Y, Chen M, et al. Mannosylated Fluoropolypeptide Nanovaccines Remodeling Tumor Immunosuppressive Microenvironment to Achieve Highly Potent Cancer Immunotherapy. Advanced Healthcare Materials. 2024;13(30). doi:10.1002/adhm.202401354

BibTeX
@article{He2024,
  author = {He, Meng and Xu, Wei and Dan, Yuxin and Pan, Yue and Li, Yingying and Chen, Mingsheng and Dong, Chang-Ming},
  title = {Mannosylated Fluoropolypeptide Nanovaccines Remodeling Tumor Immunosuppressive Microenvironment to Achieve Highly Potent Cancer Immunotherapy},
  journal = {Advanced Healthcare Materials},
  year = {2024},
  volume = {13},
  number = {30},
  doi = {10.1002/adhm.202401354}
}
Kostenlos starten →